The US Food and Drug Administration (FDA) has cited several online companies, including retail giant Amazon, for selling products that have not been evaluated for safety and efficacy by regulators. It also warned a couple of drugmakers for failing to meet its current good manufacturing practices (CGMP) requirements, including falsifying laboratory testing data.
